All Categories
Life Sciences Tools & Services
Life Sciences Tools & Services (922) | Uncategorized (922)
- 10x Genomics, Inc. (3 contracts)
- AbCellera Biologics Inc. (2)
- AbSci Corp (3)
- Adaptive Biotechnologies Corp (3)
- Agilent Technologies Inc (55)
- Akoya Biosciences, Inc. (10)
- Alpha Teknova, Inc. (8)
- ArcherDX, Inc. (2)
- ARQULE INC (16)
- ARYA Sciences Acquisition Corp III (8)
- Berkeley Lights, Inc. (1)
- Bio-Matrix Scientific Group, Inc. (35)
- Bio-Rad Laboratories (2)
- Bio-Techne (4)
- BIOANALYTICAL SYSTEMS INC (31)
- BioNano Genomics, Inc (13)
- BRUKER CORP (7)
- Cambrex Corporation (5)
- CHAMPIONS ONCOLOGY, INC. (20)
- Charles River Laboratories (29)
- ChromaDex Corp. (30)
- CM Life Sciences II Inc. (8)
- Codex DNA, Inc. (2)
- CODEXIS INC (28)
- Cytek BioSciences, Inc. (3)
- ECO SCIENCE SOLUTIONS, INC. (11)
- EMMAUS LIFE SCIENCES, INC. (22)
- EVIO, INC. (4)
- FLUIDIGM CORP (72)
- HARVARD BIOSCIENCE INC (17)
- HighCape Capital Acquisition Corp. (12)
- Illumina Inc (65)
- InventaBioTech Inc. (2)
- IQVIA Holdings Inc. (15)
- IsoPlexis Corp (6)
- Lifesci Acquisition II Corp. (12)
- Luminex Corporation (18)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (8)
- Medpace Holdings, Inc. (1)
- Mettler Toledo (7)
- Miromatrix Medical Inc. (5)
- NanoString Technologies Inc (2)
- NEOGENOMICS INC (16)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (9)
- PerkinElmer (44)
- Personalis, Inc. (7)
- Pharma-Bio Serv, Inc. (10)
- PPD, Inc. (10)
- PRA Health Sciences (5)
- PRESSURE BIOSCIENCES INC (38)
- Quanterix Corp (14)
- RAPID MICRO BIOSYSTEMS, INC. (1)
- Repligen Corporation (18)
- Seer, Inc. (8)
- SeqLL, Inc. (3)
- Singular Genomics Systems, Inc. (5)
- Sotera Health Co (6)
- Syneos Health (23)
- Thermo Fisher Scientific (52)
- VG Acquisition Corp. (20)
- Waters Corporation (26)
- Relinquishment Agreement, by and between 23andMe Holding Co. and Paul Johnson, October 21, 2021 (VG Acquisition Corp., Filed With SEC on May 25, 2023)
- Offer letter by and between Standard BioTools Inc. and Jeffery G. Black executed May 10, 2023 (FLUIDIGM CORP, Filed With SEC on May 15, 2023)
- Letter agreement by and between Standard BioTools Inc. and Vikram Jog dated May 10, 2023 (FLUIDIGM CORP, Filed With SEC on May 15, 2023)
- Offer Letter, dated January 31, 2023, by and between the Registrant and Jennifer Kamocsay (Akoya Biosciences, Inc., Filed With SEC on May 9, 2023)
- Offer Letter, dated January 30, 2023, by and between the Registrant and Johnny Ek (Akoya Biosciences, Inc., Filed With SEC on May 9, 2023)
- Confirmatory Offer Letter between the Company and Eric Esser dated May 2, 2022 (Codex DNA, Inc., Filed With SEC on May 2, 2023)
- Offer Letter for Michael Bonello, dated April 7, 2023 (Syneos Health, Filed With SEC on May 2, 2023)
- Letter from Syneos Health, Inc. to Stanford Rudnick, dated March 29, 2023 (Syneos Health, Filed With SEC on March 30, 2023)
- Description of Securities (HighCape Capital Acquisition Corp., Filed With SEC on March 17, 2023)
- Description of the Companys Securities (BioNano Genomics, Inc, Filed With SEC on March 9, 2023)
- Amended and Restated Offer Letter, dated March 7, 2023, between the Company and Christopher Hall (Personalis, Inc., Filed With SEC on March 8, 2023)
- Amendment and Incremental Commitment Agreement, dated as of March 3, 2023, by and among the Company, Waters Technologies Corporation, TA Instruments Waters L.L.C., Waters Asia... (Waters Corporation, Filed With SEC on March 7, 2023)
- Letter of Terms and Conditions U.S. Indefinite Relocation and U.S. Domestic Relocation Agreement, each by and among Padraig McDonnell and the Company (Agilent Technologies Inc, Filed With SEC on March 3, 2023)
- Description of Maravai LifeSciences Holdings, Inc.s Securities (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 28, 2023)
- Executed Restrictive Covenants Agreement by and between Sotera Health Company and Alex (Sotera Health Co, Filed With SEC on February 28, 2023)
- Executed Restrictive Covenants Agreement by and between Sotera Health Company and Michael F. Biehl dated as of July (Sotera Health Co, Filed With SEC on February 28, 2023)
- Offer Letter by and between the Company and Sriram Ryali dated as of December 30, 2023 (CODEXIS INC, Filed With SEC on February 27, 2023)
- Offer Letter by and between the Company and Margaret Fitzgerald dated as of October 5, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
- Description of the Registrants Securities (Thermo Fisher Scientific, Filed With SEC on February 23, 2023)
- Description of Securities (ARYA Sciences Acquisition Corp III, Filed With SEC on February 23, 2023)
- Letter Agreement between the Company and Costa Panagos, effective on April 1, 2022 (IQVIA Holdings Inc., Filed With SEC on February 15, 2023)
- Letter Agreement between Jennifer Cote and the Company dated December 29, 2022 (HARVARD BIOSCIENCE INC, Filed With SEC on January 3, 2023)
- Offer Letter between Jennifer Cote and the Company dated April 28, 2022 (HARVARD BIOSCIENCE INC, Filed With SEC on January 3, 2023)
- Letter Agreement by and between Marc N. Casper and Thermo Fisher Scientific Inc., dated as of November 10, 2022 (Thermo Fisher Scientific, Filed With SEC on November 14, 2022)
- Offer Letter by and between the Company and Kevin Norrett (CODEXIS INC, Filed With SEC on November 4, 2022)
- Contract No. 36C24E22D0031, by and between the U.S. Department of Veterans Affairs and the Registrant, dated September 30, 2022 (Personalis, Inc., Filed With SEC on November 2, 2022)
- Offer Letter dated October 4, 2022, between Chris Williams and the Company (Cytek BioSciences, Inc., Filed With SEC on November 1, 2022)
- SEER, INC. CONSULTANT AGREEMENT (Seer, Inc., Filed With SEC on August 26, 2022)
- Letter Agreement with Kevin Farr (ChromaDex Corp., Filed With SEC on August 10, 2022)
- Consultant Agreement with Kevin Farr (ChromaDex Corp., Filed With SEC on August 10, 2022)
- Offer Letter, dated April 1, 2022, by and between Registrant and Ehab El-Gabry (Akoya Biosciences, Inc., Filed With SEC on August 9, 2022)
- Offer Letter between Nautilus Biotechnology, Inc. and (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2022)
- Agreement between Syneos Health UK Limited and Alistair Macdonald, dated April 29, 2022 and July 8, 2022 (Syneos Health, Filed With SEC on August 2, 2022)
- Description of Registered Securities (CHAMPIONS ONCOLOGY, INC., Filed With SEC on July 22, 2022)
- Description of 23andMe Holding Co.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (VG Acquisition Corp., Filed With SEC on May 27, 2022)
- Executive Chair and Principal Executive Officer agreement between NeoGenomics, Inc. and Lynn A. Tetrault dated April 25, 2022 (NEOGENOMICS INC, Filed With SEC on May 9, 2022)
- Amended and Restated 2020 E (Seer, Inc., Filed With SEC on May 6, 2022)
- Offer Letter between Nautilus Biotechnology, Inc. and Gwen Weld dated March 28, 2022 (ARYA Sciences Acquisition Corp III, Filed With SEC on May 3, 2022)
- Letter Agreement between the Company and Michelle Keefe, dated April 29, 2022 (Syneos Health, Filed With SEC on April 29, 2022)
- Agreement between Syneos Health UK Limited and Alistair Macdonald, dated April 29, 2022 (Syneos Health, Filed With SEC on April 29, 2022)
